Important Shipping Update: Due to the current cold weather conditions, we’re experiencing possible delays in our shipping schedule. We are working closely with our carriers to ensure your orders are delivered as quickly and safely as possible. Thank you for your patience and understanding.
Use this bar to show information about your cookie policy.
Description
RYZUMVI (Phentolamine Ophthalmic Solution) 0.75% is indicated for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g.phenylephrine) or parasympatholytic (e.g.tropicamide) agents. The only available FDA-approved treatment for the reversal of pharmacologically-induced mydriasis.
